Wall Street Loves this New Immunotherapy Cancer Drug

As new immunotherapy drugs hope to turn metastatic cancer into a chronic manageable condition, or at least significantly prolong life in the near term, investors are understandably excited about their potential.

And one company at the forefront of this move, Bristol-Myers Squibb, just got a huge upgrade today from Wall Street titan Citigroup, sending shares 5% higher. Citi moved Bristol from "neutral" to "buy" and upped its old $33 price target to $55 per share.

In this video, health-care analyst David Williamson discusses Bristol's big upgrade and gives a few of his key takeaways from the report.

Another topic health care investors need to keep up on is Obamacare, as the law will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio will be affected. Click here to read more. 

Follow David on Twitter: @MotleyDavid.

Read/Post Comments (0) | Recommend This Article (1)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2448274, ~/Articles/ArticleHandler.aspx, 9/29/2016 2:59:46 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,200.87 -138.37 -0.75%
S&P 500 2,159.83 -11.54 -0.53%
NASD 5,286.06 -32.49 -0.61%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 2:44 PM
BMY $54.06 Down -1.03 -1.87%
Bristol-Myers Squi… CAPS Rating: ****
RHHBY $31.20 Down -0.37 -1.17%
Roche Holding Ltd.… CAPS Rating: *****